Estrogen receptor-α (ER-α), progesterone receptor (PR), and epidermal growth factor receptor 2 (ERBB2, HER-2/neu) are the most commonly used biomarkers for BC, and their status determines the main BC subtypes. Here, ERBB2 is linked to breast cancer.